A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF
This is a Phase 2, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of sotatercept versus placebo in adults with Cpc-PH due to HFpEF. The objective of this study